Acute Lymphoblastic Leukemia News and Research

RSS
Acute lymphoblastic leukemia (ALL) is a cancer of the white blood cells, the cells in the body that normally fight infections. There are two main types of white blood cells-lymphoid cells and myeloid cells. ALL affects lymphoid cells.
Researchers unravel how ALL invades the central nervous system

Researchers unravel how ALL invades the central nervous system

Staggering prices slow insurers’ coverage of CAR-T cancer therapy

Staggering prices slow insurers’ coverage of CAR-T cancer therapy

Scientists engineer bi-specific antibodies that attract immune killers directly to cancer cells

Scientists engineer bi-specific antibodies that attract immune killers directly to cancer cells

Study reveals rate of vertebral and non-vertebral fractures in children with leukemia

Study reveals rate of vertebral and non-vertebral fractures in children with leukemia

New treatment regimen boosts survival for young adults and children with T-cell malignancies

New treatment regimen boosts survival for young adults and children with T-cell malignancies

New case study shows CAR T therapy as viable option for AML patients

New case study shows CAR T therapy as viable option for AML patients

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

Scientists identify key genetic events responsible for initiating childhood leukemia

Scientists identify key genetic events responsible for initiating childhood leukemia

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

Leukemia itself may increase risk for long-term neurocognitive problems in survivors

Leukemia itself may increase risk for long-term neurocognitive problems in survivors

Researchers show how two cancer genes work together to trigger leukemia

Researchers show how two cancer genes work together to trigger leukemia

Gene-editing technology enhances T cell immunotherapies for treating cancer

Gene-editing technology enhances T cell immunotherapies for treating cancer

Historic study involving Simmons Cancer Center shows effectiveness of CAR-T therapy

Historic study involving Simmons Cancer Center shows effectiveness of CAR-T therapy

Newly identified germline variations increase risk of relapse or second cancers in leukemia patients

Newly identified germline variations increase risk of relapse or second cancers in leukemia patients

Clinical benefit of new cancer therapies may justify the expensive price

Clinical benefit of new cancer therapies may justify the expensive price

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

Clinical study uses genetic testing to match AML patients with new therapies

Clinical study uses genetic testing to match AML patients with new therapies

Australian researchers develop new risk scoring system to predict childhood leukemia relapse

Australian researchers develop new risk scoring system to predict childhood leukemia relapse

UNC Lineberger professor receives The Leukemia & Lymphoma Society grant for immunotherapy research

UNC Lineberger professor receives The Leukemia & Lymphoma Society grant for immunotherapy research

CHLA receives more than $1 million from St. Baldrick's Foundation for cancer research

CHLA receives more than $1 million from St. Baldrick's Foundation for cancer research